434 related articles for article (PubMed ID: 1720090)
1. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
2. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
Welsh N; Sandler S
Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791
[TBL] [Abstract][Full Text] [Related]
4. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta.
Scarim AL; Heitmeier MR; Corbett JA
Endocrinology; 1997 Dec; 138(12):5301-7. PubMed ID: 9389514
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
6. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function.
Welsh N; Sandler S
Mol Cell Endocrinol; 1994 Jul; 103(1-2):109-14. PubMed ID: 7958387
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
[TBL] [Abstract][Full Text] [Related]
8. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
[TBL] [Abstract][Full Text] [Related]
9. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide.
Corbett JA; Kwon G; Turk J; McDaniel ML
Biochemistry; 1993 Dec; 32(50):13767-70. PubMed ID: 7505613
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
[TBL] [Abstract][Full Text] [Related]
11. The nitric oxide synthase II inhibitor NG-nitro-L-arginine stimulates pancreatic islet insulin release in vitro, but not in the perfused pancreas.
Jansson L; Sandler S
Endocrinology; 1991 Jun; 128(6):3081-5. PubMed ID: 1709860
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
14. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets.
Scarim AL; Heitmeier MR; Corbett JA
Endocrinology; 1998 Dec; 139(12):5050-7. PubMed ID: 9832444
[TBL] [Abstract][Full Text] [Related]
15. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
16. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
[TBL] [Abstract][Full Text] [Related]
17. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
[TBL] [Abstract][Full Text] [Related]
18. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
Xenos ES; Stevens RB; Gores PF; Casanova D; Farney AC; Sutherland DE; Platt JL
Transplant Proc; 1993 Feb; 25(1 Pt 2):994. PubMed ID: 7680174
[No Abstract] [Full Text] [Related]
19. Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine.
Andersen HU; Mauricio D; Karlsen AE; Mandrup-Poulsen T; Nielsen JH; Nerup J
Eur J Endocrinol; 1996 Feb; 134(2):251-9. PubMed ID: 8630528
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta.
Bolaffi JL; Rodd GG; Wang J; Grodsky GM
Endocrinology; 1994 Feb; 134(2):537-42. PubMed ID: 7507826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]